1990
DOI: 10.1038/346866a0
|View full text |Cite
|
Sign up to set email alerts
|

Telomere reduction in human colorectal carcinoma and with ageing

Abstract: We have hypothesized that end-to-end chromosome fusions observed in some tumours could play a part in genetic instability associated with tumorigenesis and that fusion may result from the loss of the long stretches of G-rich repeats found at the ends of all linear chromosomes. We therefore asked whether there is telomere loss or reduction in common tumours. Here we show that in most of the colorectal carcinomas that we analysed, there is a reduction in the length of telomere repeat arrays relative to the norma… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

46
876
4
11

Year Published

1997
1997
2010
2010

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 1,546 publications
(937 citation statements)
references
References 25 publications
46
876
4
11
Order By: Relevance
“…17,18,30 Shortened telomeres have been identified in a variety of invasive cancers and preinvasive lesions of the pancreas and prostate, and telomere shortening may be a critical early event in the development of epithelial neoplasms. 13,14,31,32 In addition to telomere shortening observed in dysplastic and carcinoma specimens, the majority of metaplastic lesions of the gallbladder in this study also demonstrated telomere shortening, supporting prior genetic evidence that metaplastic change in the gallbladder represents an early neoplastic alteration. 7 Specifically, in the study of Wistuba et al, 7 gallbladder metaplasias showed loss of heterozygosity in at least one cancer-associated locus in four of five cases.…”
Section: Discussionsupporting
confidence: 82%
“…17,18,30 Shortened telomeres have been identified in a variety of invasive cancers and preinvasive lesions of the pancreas and prostate, and telomere shortening may be a critical early event in the development of epithelial neoplasms. 13,14,31,32 In addition to telomere shortening observed in dysplastic and carcinoma specimens, the majority of metaplastic lesions of the gallbladder in this study also demonstrated telomere shortening, supporting prior genetic evidence that metaplastic change in the gallbladder represents an early neoplastic alteration. 7 Specifically, in the study of Wistuba et al, 7 gallbladder metaplasias showed loss of heterozygosity in at least one cancer-associated locus in four of five cases.…”
Section: Discussionsupporting
confidence: 82%
“…Telomere attrition in the absence of telomerase has been shown to be an intrinsic timing mechanism that controls the number of somatic cell divisions prior to senescence (Harley et al, 1990;Hastie et al, 1990;Counter et al, 1992;Bodnar et al, 1998). The prominence of TERT in telomere homeostasis and the pro®le of TERT gene expression in normal and neoplastic settings prompted us to determine whether various cellular growth control and transcriptional factors regulate TERT gene expression and/or telomerase activity in primary human lung ®broblasts.…”
Section: Discussionmentioning
confidence: 99%
“…[15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][46][47][48][49] Previous studies in childhood and adult leukemia have suggested that telomerase activity and short tel-(one Ewing's sarcoma, one Wilms' tumor) revealed two peak TRF values at diagnosis (peak 1: 11.7 kbp, peak 2: 7.8 kbp)…”
Section: Bone Marrow (Bm) 31mentioning
confidence: 99%
“…From our (PD). 3,12,19,25,[56][57][58] In this study, we analyzed mean and peak values, since the acquisition of mean TRF values alone may results, one can hypothesize that telomere length shortening reflects a possible effect on all cells including somatic cells be inaccurate. In acute leukemia, most BM and PB specimens allowed the detection of two peaks: the longer corresponding which would then lead to premature aging, unless telomeres can recover, elongate and potentially gain their initial length to normal cells, correlating with telomeres of granulocyte controls, and the shorter peak corresponding to the leukemic after discontinuation of chemotherapy.…”
Section: Bone Marrow (Bm) 31mentioning
confidence: 99%